AGRX Agile Therapeutics, Inc. Stock Quote

AGRX [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-0.70	Insider Own	0.80%	Shs Outstand	87.63M	Perf Week	-22.45%
Market Cap	119.79M	Forward P/E	-	EPS next Y	-0.16	Insider Trans	11.19%	Shs Float	67.10M	Perf Month	-31.44%
Income	-61.10M	PEG	-	EPS next Q	-0.20	Inst Own	49.00%	Short Float	7.14%	Perf Quarter	-63.16%
Sales	0.90M	P/S	133.10	EPS this Y	-62.70%	Inst Trans	-4.12%	Short Ratio	3.18	Perf Half Y	-54.45%
Book/sh	0.40	P/B	3.33	EPS next Y	75.80%	ROA	-75.20%	Target Price	-	Perf Year	-53.33%
Cash/sh	0.45	P/C	2.99	EPS next 5Y	-	ROE	-105.70%	52W Range	1.38 - 3.89	Perf YTD	-53.66%
Dividend	-	P/FCF	-	EPS past 5Y	15.00%	ROI	-74.70%	52W High	-65.81%	Beta	0.98
Dividend %	-	Quick Ratio	4.80	Sales past 5Y	-	Gross Margin	-66.80%	52W Low	-3.62%	ATR	0.12
Employees	28	Current Ratio	5.00	Sales Q/Q	-	Oper. Margin	-	RSI (14)	22.38	Volatility	10.07% 6.73%
Optionable	Yes	Debt/Eq	0.44	EPS Q/Q	-90.10%	Profit Margin	-	Rel Volume	1.46	Prev Close	1.41
Shortable	Yes	LT Debt/Eq	0.44	Earnings	May 04 AMC	Payout	-	Avg Volume	1.50M	Price	1.33
Recom	1.60	SMA20	-24.40%	SMA50	-33.10%	SMA200	-51.15%	Volume	2,190,363	Change	-5.67%

Apr-07-21

Resumed

RBC Capital Mkts

Outperform

Apr-12-19

Resumed

Janney

Buy

Nov-29-18

Initiated

Maxim Group

Buy

Dec-26-17

Downgrade

William Blair

Outperform → Mkt Perform

Dec-26-17

Downgrade

Janney

Buy → Neutral

Oct-02-17

Resumed

H.C. Wainwright

Buy

$10

Sep-14-17

Reiterated

RBC Capital Mkts

Outperform

$8 → $10

Jul-19-17

Initiated

H.C. Wainwright

Buy

$10

Jan-08-16

Initiated

Cantor Fitzgerald

Buy

Apr-02-15

Initiated

FBR Capital

Outperform

$17

Jun-17-14

Initiated

William Blair

Outperform

Jun-17-14

Initiated

RBC Capital Mkts

Outperform

$12

May-05-21 08:01AM	Agile Therapeutics (AGRX) Q1 2021 Earnings Call Transcript Motley Fool -11.95%
May-04-21 07:15PM	Agile Therapeutics (AGRX) Reports Q1 Loss, Lags Revenue Estimates Zacks
04:05PM	Agile Therapeutics Reports First Quarter 2021 Financial Results GlobeNewswire
02:30PM	Agile Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
Apr-30-21 11:01AM	Agile Therapeutics Announces Presentation of Safety and Efficacy Data of Twirla® (Levonorgestrel and Ethinyl Estradiol) Transdermal System in Women of Differing BMI Categories at ACOG Annual Meeting GlobeNewswire
Apr-20-21 10:56AM	CORRECTING AND REPLACING -- Agile Therapeutics GlobeNewswire
09:30AM	Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2020 GlobeNewswire
Apr-09-21 02:16PM	7 Beaten Down Stocks with Significant Insider Buying InvestorPlace
Mar-05-21 07:30AM	Agile Therapeutics to Present at Upcoming March Investor Conferences GlobeNewswire
Mar-01-21 11:31PM	Agile Therapeutics (AGRX) Q4 2020 Earnings Call Transcript Motley Fool +5.23%
06:15PM	Agile Therapeutics (AGRX) Reports Q4 Loss, Misses Revenue Estimates Zacks
04:05PM	Agile Therapeutics Reports Fourth Quarter & Full Year 2020 Financial Results; Expands Loan Facility With Perceptive Advisors GlobeNewswire
Feb-19-21 08:35AM	Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021 GlobeNewswire
Jan-04-21 12:18PM	Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference GlobeNewswire
Jan-03-21 11:12PM	Are Institutions Heavily Invested In Agile Therapeutics, Inc.'s (NASDAQ:AGRX) Shares? Simply Wall St.
Dec-21-20 07:30AM	Agile Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-12-20 01:23PM	Is AGRX A Good Stock To Buy Now? Insider Monkey
Dec-07-20 07:30AM	Agile Therapeutics Announces Nationwide Commercial Launch and Availability of Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System, a New Non-Daily, Non-Invasive Contraceptive Patch GlobeNewswire
Nov-30-20 09:11AM	Agile Therapeutics Announces Peer-Reviewed Publication of Phase 3 SECURE Study Results for Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System in Contraception GlobeNewswire
Nov-23-20 10:00AM	Agile Therapeutics to Participate in the 32nd Annual Piper Sandler Healthcare Conference GlobeNewswire
Nov-13-20 06:02AM	Agile Therapeutics' Q3 Focused on Launching Its New Contraceptive Patch Motley Fool
Nov-12-20 04:05PM	Agile Therapeutics Reports Third Quarter 2020 Financial Results GlobeNewswire
01:00PM	Agile Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
Nov-04-20 07:30AM	Agile Therapeutics to Host Third Quarter 2020 Financial Results Conference Call and Provide Corporate and Twirla® Commercial Updates on Thursday, November 12, 2020 GlobeNewswire
Sep-22-20 11:40AM	Agile Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit GlobeNewswire -8.80%
Sep-09-20 08:00AM	Agile Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference GlobeNewswire
Sep-08-20 08:00AM	Agile Therapeutics Announces Virtual Investor/Analyst Day on Monday, September 21, 2020 GlobeNewswire
Sep-02-20 09:00AM	Agile Therapeutics Launches Im So Done Campaign to Inspire Women to Take an Active Role in Choosing their Birth Control GlobeNewswire
Aug-17-20 08:00AM	Agile Therapeutics Strengthens Executive Leadership Team with the Appointment of Paul Korner, MD, MBA, as Chief Medical Officer GlobeNewswire
Aug-11-20 04:02PM	Agile Therapeutics to Participate in Maxim Groups Leading Innovators in Womens Health Virtual Conference GlobeNewswire
04:01PM	Agile Therapeutics Reports Second Quarter 2020 Financial Results GlobeNewswire
Jul-21-20 07:30AM	Agile Therapeutics to Host Second Quarter 2020 Financial Results and Business Update Conference Call on Tuesday, August 11, 2020 GlobeNewswire
Jul-01-20 01:22AM	Hedge Funds Have Never Been This Bullish On Agile Therapeutics Inc (AGRX) Insider Monkey
Jun-23-20 08:30AM	How Agile Therapeutics (AGRX) Stock Stands Out in a Strong Industry Zacks
Jun-16-20 08:00AM	Agile Therapeutics to Join Russell 3000® and 2000® Indexes GlobeNewswire
Jun-10-20 09:35AM	Billionaire Israel Englander Bets on These 3 Penny Stocks TipRanks
May-28-20 12:37PM	Edited Transcript of AGRX earnings conference call or presentation 5-May-20 8:30pm GMT Thomson Reuters StreetEvents -9.09%
May-11-20 04:05PM	Agile Therapeutics to Participate in Virtual Fireside Chat as part of the 2020 RBC Capital Markets Global Healthcare Conference on Wednesday, May 20, 2020 GlobeNewswire +10.04%
May-07-20 08:36AM	Is the Options Market Predicting a Spike in Agile Therapeutics (AGRX) Stock? Zacks
May-05-20 04:01PM	Agile Therapeutics Reports First Quarter 2020 Financial Results GlobeNewswire
May-04-20 12:07PM	Why Agile Therapeutics Stock Is Jumping Today Motley Fool
Apr-23-20 07:30AM	Agile Therapeutics to Host First Quarter 2020 Financial Results and Business Update Conference Call on Tuesday, May 5, 2020 GlobeNewswire
Apr-22-20 08:00AM	Agile Therapeutics Announces Changes to its Board of Directors GlobeNewswire
Apr-01-20 05:50PM	Agile Therapeutics (AGRX) Flat As Market Sinks: What You Should Know Zacks
Mar-23-20 04:31PM	Agile Therapeutics (AGRX) Stock Remains a Top Pick, Says Analyst TipRanks
Mar-18-20 08:49AM	Implied Volatility Surging for Agile Therapeutics (AGRX) Stock Options Zacks -6.18%
Mar-15-20 04:02PM	Weekly CFO Buys Highlight GuruFocus.com
Mar-03-20 03:00PM	7 Cheap Stocks Under $7 With Massive Upside Potential Kiplinger -8.66%
Feb-25-20 11:41AM	Agile Therapeutics, Inc. (Nasdaq: AGRX) to Ring Nasdaq Stock Market Closing Bell on Wednesday, February 26, 2020 GlobeNewswire
Feb-21-20 12:00PM	Agile Therapeutics (AGRX) Upgraded to Buy: Here's Why Zacks -13.55%
11:30AM	Is Agile Therapeutics (AGRX) Stock Outpacing Its Medical Peers This Year? Zacks
08:35AM	Agile Therapeutics Announces Pricing of $45 Million Underwritten Public Offering of Common Stock GlobeNewswire
07:46AM	The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion Benzinga
Feb-20-20 04:14PM	Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock GlobeNewswire
04:01PM	Agile Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire
Feb-14-20 06:46PM	FDA Approves Agile Therapeutics, Inc.s Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System A New Weekly Contraceptive Patch Delivering a 30 mcg Daily Dose of Estrogen and 120 mcg Daily Dose of Progestin GlobeNewswire
Feb-12-20 09:18AM	The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data Benzinga
Feb-11-20 08:46AM	Agile Finalizes $35M Term Loan Facility As Twirla PDUFA Date Looms Benzinga +9.73%
Feb-10-20 04:30PM	Agile Therapeutics, Inc. Enters into up to $35 Million Loan Facility with Perceptive Advisors GlobeNewswire
Feb-03-20 01:30PM	Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates Benzinga
Jan-28-20 01:48PM	5 'Strong Buy' Biotech Stocks With Rapidly Approaching Catalysts Kiplinger +14.96%
Jan-10-20 09:33AM	The Zacks Analyst Blog Highlights: Agile Therapeutics, Air Industries, Dermira, Microbot Medical and Cassava Sciences Zacks
Jan-09-20 06:19AM	Buy Multibagger Stocks as Odds of a Rally Are High in 2020 Zacks
Jan-07-20 10:22AM	The Zacks Analyst Blog Highlights: Agile Therapeutics, Ares Capital, Cable One, Evolution Petroleum and Royal Gold Zacks
Jan-06-20 08:14AM	Here's How to Play Stocks as US-Iran Tensions Mount Zacks
08:00AM	Agile Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco GlobeNewswire
Jan-03-20 07:55AM	The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger Benzinga
Jan-02-20 08:00AM	Agile Therapeutics Strengthens Commercial Leadership Team GlobeNewswire +18.80%
Dec-23-19 08:36AM	Implied Volatility Surging for Agile Therapeutics (AGRX) Stock Options Zacks +7.20%
Dec-19-19 04:05PM	Agile Therapeutics to Present at Biotech Showcase 2020 in San Francisco GlobeNewswire +6.98%
Dec-14-19 06:59PM	Hedge Funds Have Never Been More Bullish On Agile Therapeutics Inc (AGRX) Insider Monkey
Nov-15-19 10:09AM	The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval Benzinga -37.39%
Nov-14-19 04:30PM	Agile Therapeutics Announces FDA Extension of Twirla® NDA Review Period GlobeNewswire +10.19%
Nov-11-19 04:40PM	RBC: 3 Stock Picks Set to Soar 30%+ TipRanks
Nov-05-19 06:53AM	The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment Benzinga +34.83%
Nov-04-19 11:24AM	Agile (AGRX) Stock Surges Over 370%, Whats Next? TipRanks +31.85%
Oct-31-19 01:11PM	Agile Therapeutics' stock rockets nearly 4-fold after contraceptive patch Twirla gets favorable FDA committee nod MarketWatch +223.80%
10:52AM	Agile Therapeutics Rallies After FDA Panel Backs Contraceptive Patch Benzinga
08:34AM	Benzinga Pro's Top 5 Stocks To Watch For Thurs., Oct. 31, 2019: AAPL, FB, AGRX, X, CROX Benzinga
Oct-30-19 06:33PM	Agile Therapeutics Announces Favorable Outcome of FDA Advisory Committee Meeting for its Investigational Transdermal Contraceptive Patch, Twirla® (AG200-15) GlobeNewswire
Oct-29-19 05:24PM	Agile (AGRX): Should You Catch this Falling Knife? TipRanks -17.92%
07:32AM	The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study Benzinga
Oct-28-19 08:00AM	Agile Therapeutics Reports Third Quarter 2019 Financial Results GlobeNewswire -59.32%
Oct-25-19 09:30AM	Is Agile Therapeutics (AGRX) Outperforming Other Medical Stocks This Year? Zacks
09:00AM	Agile Therapeutics (AGRX) Upgraded to Buy: Here's What You Should Know Zacks
Oct-14-19 12:17AM	3 Top Biotech Stocks With Major Catalysts in October TipRanks
Oct-01-19 09:44AM	The Zacks Analyst Blog Highlights: Barrett Business Services, Hibbett Sports, Construction Partners, Agile Therapeutics and Boot Barn Zacks
Sep-30-19 11:16PM	Penny Stocks to Buy Using Technical Analysis for October 2019 Investopedia +5.80%
08:05AM	Trade Worries Resurface! Buy These 5 U.S. Stocks Now Zacks
Sep-25-19 08:23AM	Top Ranked Momentum Stocks to Buy for September 25th Zacks -5.45%
Sep-19-19 10:29AM	Zynerba Releases Data on Epilepsy Candidate, Stock Down Zacks -8.53%
Sep-10-19 09:00AM	Agile Therapeutics (AGRX) Upgraded to Strong Buy: Here's What You Should Know Zacks
Sep-06-19 07:30AM	Agile Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire +9.60%
Sep-05-19 10:12AM	3 Strong Buy Biotech Stocks Ahead of FDA Verdicts SmarterAnalyst +9.65%
Aug-30-19 09:45AM	Agile (AGRX) Stock Could Be Ready to Break Out TipRanks
Aug-22-19 10:50AM	New Strong Buy Stocks for August 22nd Zacks
Aug-08-19 04:15PM	Agile Therapeutics Announces Full Exercise of Over-Allotment Option by Underwriters GlobeNewswire
Aug-02-19 09:05AM	Agile Therapeutics Announces Pricing of $12 Million Underwritten Public Offering of Common Stock GlobeNewswire -9.55%
Aug-01-19 04:01PM	Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock GlobeNewswire -5.17%
08:00AM	Agile Therapeutics Reports Second Quarter 2019 Financial Results GlobeNewswire

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Butch Jason	Principal Accounting Officer	Mar 29	Buy	1.99	1,358	2,702	20,000	Mar 30 04:48 PM
Butch Jason	Principal Accounting Officer	Mar 26	Buy	2.01	8,642	17,370	18,642	Mar 30 04:48 PM
Reilly Dennis	Chief Financial Officer	Mar 23	Buy	2.05	50,000	102,500	156,306	Mar 23 05:23 PM
ALTOMARI ALFRED	Chief Executive Officer	Mar 23	Buy	2.00	12,500	25,030	468,710	Mar 23 05:24 PM
Conway Robert G	SVP Chief Supply Chain Officer	Nov 19	Option Exercise	1.76	4,149	7,302	22,896	Nov 23 05:00 PM
Reilly Dennis	Chief Financial Officer	Sep 28	Buy	2.85	9,000	25,650	106,306	Sep 28 04:10 PM
ALTOMARI ALFRED	Chief Executive Officer	Aug 20	Option Exercise	1.76	94,599	166,494	456,210	Aug 20 04:15 PM
ALTOMARI ALFRED	Chief Executive Officer	Jun 22	Option Exercise	1.76	50,000	88,000	361,611	Jun 23 05:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience